加拿大生育与男科学会非整倍体植入前遗传学检测指南
该指南由加拿大生育与男科学会制定,采用GRADE框架综合滋养层活检与24染色体分析用于非整倍体植入前遗传学检测(PGT-A)的证据并给出临床推荐。随机对照试验仅限于能产生两个及以上可活检囊胚的良好预后患者,该人群中PGT-A提高每移植周期的植入率和持续妊娠或分娩率,但不宜外推至整体不孕人群,应用应个体化并充分知情同意。
要点
- PGT-A应个体化应用,年龄和获得胚胎能力影响决策。
- 良好预后患者中PGT-A提高每移植周期植入率和持续妊娠或分娩率。
- 需权衡获益与技术成本及局限,包括胚胎损伤和嵌合体检测风险。
核心结论
- 现有随机对照试验仅支持PGT-A在能产生两个及以上可活检囊胚的良好预后患者中提高每移植周期植入率和持续妊娠或分娩率,不能推广至整体不孕人群。
研究设计与样本
- 加拿大生育与男科学会指南,采用GRADE框架综合滋养层活检与24染色体分析用于PGT-A的证据并形成临床推荐。
主要发现
- 随机对照试验限于能产生两个及以上可活检囊胚的良好预后患者。
- 该人群中GRADE分析显示PGT-A提高每移植周期植入率和持续妊娠或分娩率。
关键数值与推荐
- PGT-A应用应个体化,年龄和获得胚胎能力等因素影响决策。
- 实施PGT-A前必须进行全面患者咨询和知情同意。
- 需权衡潜在获益与技术成本及局限,包括胚胎损伤、假阳性、假阴性和胚胎嵌合体检测风险。
临床怎么用
- 对良好预后且能获得两个及以上可活检囊胚的患者可考虑PGT-A以改善每移植周期结局。
- 决策前结合患者年龄和获胚能力个体化评估,并完成充分咨询与知情同意。
局限性
- 随机对照试验证据仅限于良好预后患者,难以外推至整体不孕人群。
- 未来需研究PGT-A在较差预后患者中的应用及按周期启动和累计取卵报告结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this guideline from the Canadian Fertility and Andrology Society is to synthesize the evidence on preimplantation genetic testing for aneuploidies (PGT-A) using trophectoderm biopsy and 24-chromosome analysis and to provide clinical recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. To date, randomized controlled trials have been limited to good-prognosis patients who were able to generate two or more blastocysts for biopsy. In this specific population the GRADE analysis of PGT-A shows an increase in the implantation rate and ongoing pregnancy or delivery rate per transfer. Clearly, it is difficult to generalize from this subgroup of patients to the infertility population at large. As a result, the application of PGT-A should be individualized, and patient factors such as age and ability to generate embryos will influence decision-making. Comprehensive patient counselling and informed consent are imperative before undertaking PGT-A. Potential benefits must be weighed against the costs and limitations of the technology, including the risk of embryo damage, false positives, false negatives and the detection of embryonic mosaicism. Future research is required, especially with regard to the use of PGT-A in poorer prognosis patients, and with respect to reporting outcomes per cycle start and cumulatively per retrieval.
引用
- Chan C, Ryu M, Zwingerman R, et al. Preimplantation genetic testing for aneuploidy: A Canadian Fertility and Andrology Society Guideline. Reprod Biomed Online. 2020. PMID: 33303366. doi:10.1016/j.rbmo.2020.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。